Authors: LAVOISY J MARSAC J

Citation: J. Lavoisy et J. Marsac, ZOLPIDEM IN PARKINSONS-DISEASE, Lancet, 350(9070), 1997, pp. 74-74

Authors: REDIER H DAURES JP MICHEL C PROUDHON H VERVLOET D CHARPIN D MARSAC J DUSSER D BRAMBILLA C WALLAERT B KOPFERSCHMITT MC PAULI G TAYTARD A COGIS O MICHEL FB GODARD P

Citation: H. Redier et al., ASSESSMENT OF THE SEVERITY OF ASTHMA BY AN EXPERT-SYSTEM - DESCRIPTION AND EVALUATION, American journal of respiratory and critical care medicine, 151(2), 1995, pp. 345-352

Authors: GRANDORDY BM DECARVALHO JP REGNARD J FLORENTIN D DELAUTURE D MARSAC J LOCKHART A

Citation: Bm. Grandordy et al., THE EFFECT OF INTRAVENOUS PHENYLEPHRINE ON AIRWAY CALIBER IN ASTHMA, The European respiratory journal, 8(4), 1995, pp. 624-631

Authors: BOURIN M ALLAIN H ATASSI G BLANCHARD JC BLIN O BOST PE BRAQUET P CHAUMETRIFFAUD D DANGUMAU J ELIA AF HOUDEBINE LM LECHAT P LECOMTE JM LEFUR G LEHNER JP MARSAC J PETIT P SASSARD J SYROTA A VILAINE JP

Citation: M. Bourin et al., THE FUTURE OF PHARMACOLOGICAL MODELS, Therapie, 50(4), 1995, pp. 375-379

Authors: CAPRI S GALLUS G GRASSI C HUCHON GJ IRVINE SH LOPEZVIDRIERO MT LUISETTI M LUNGARELLA G MARRIOTT C MARSAC J RENNARD SI TABUSSO G TORRENT J

Citation: S. Capri et al., RECOMMENDATIONS FOR GUIDELINES ON CLINICAL-TRIALS OF MUCOACTIVE DRUGSIN CHRONIC-BRONCHITIS AND CHRONIC OBSTRUCTIVE PULMONARY-DISEASE, Chest, 106(5), 1994, pp. 1532-1537